A phase II study of single agent bortezomib in patients with metastatic breast cancer: a single institution experience.

Abstract:

:PS-341, now known as bortezomib (Velcade[Millenium Pharmaceuticals, Inc., Cambridge, MA; and Johnson & Johnson Pharmaceutical Research & Development, LLC, Spring house, PA]), is a proteasome inhibitor approved for the treatment of refractory multiple myeloma. Preclinical and early clinical studies showed PS-341 to be effective in solid tumors, one of which was breast cancer. We conducted a single institution, phase II study using PS-341 in the treatment of patients with metastatic breast cancer. The primary objective of this study was to determine the objective tumor response in patients with metastatic breast cancer (MBC) receiving PS-341. The secondary objectives were to estimate progression-free survival of patients receiving single-agent PS-341 and to evaluate toxicity related to PS-341. In all 12 patients who met criteria for enrollment, there were no observed objective responses. Further, all 12 patients progressed while receiving therapy with PS-341. This study was terminated after the first stage due to the lack of any objective response.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Engel RH,Brown JA,Von Roenn JH,O'Regan RM,Bergan R,Badve S,Rademaker A,Gradishar WJ

doi

10.1080/07357900701506573

subject

Has Abstract

pub_date

2007-12-01 00:00:00

pages

733-7

issue

8

eissn

0735-7907

issn

1532-4192

pii

783100851

journal_volume

25

pub_type

杂志文章
  • A novel 3-d model of chick chorioallantoic membrane for ameliorated studies in angiogenesis.

    abstract::Decisive indulgence of angiogenesis requires a more holistic assessment and several in vivo assays have been developed that permit a more realistic appraisal of the angiogenic response. One of the most popular assays to study angiogenic activity is the chick chorioallantoic membrane (CAM). Although CAM assay is a vita...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900600894773

    authors: Ejaz S,Chekarova I,Ashraf M,Lim CW

    更新日期:2006-10-01 00:00:00

  • Glyoxalase I Glu111Ala polymorphism in patients with breast cancer.

    abstract::Effect of advanced glycation end products (AGEs) in the pathogenesis of cancer could be diminished by interaction with soluble RAGE or by reducing AGE-precursors via glyoxalase I. Glu111Ala polymorphism of glyoxalase I gene, AGEs, and sRAGE serum levels were studied in 113 breast cancer patients and in 58 controls. Hi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802350822

    authors: Germanová A,Germanová A,Tesarová P,Jáchymová M,Zvára K,Zima T,Kalousová M

    更新日期:2009-07-01 00:00:00

  • Postradiation squamous cell cancer of the breast.

    abstract::Primary squamous cell carcinoma of the breast is a rare clinical entity. We diagnosed a patient who presented with a pure squamous cell cancer of the breast 12 years after local radiation for a primary adenocarcinoma of breast. Previously reported cancers related to radiation of the breast have been squamous cell of s...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900009012177

    authors: Singh H,Williams SP,Kinsella V,Lynch GR

    更新日期:2000-01-01 00:00:00

  • Effect of plasma fibronectin, macrophages, and glycosaminoglycans on tumor cell growth.

    abstract::Fibronectin (Fn) synergizes with macrophages (M phi) in inducing cytostasis and cytotoxicity of neoplastic cells in culture. Since heparin enhances Fn's opsonic activity in many systems, we investigated its effect on Fn-macrophage synergy in cytostasis. MCG-T14 (a spontaneous mouse mammary adenocarcinoma) cells (4 X 1...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908409040310

    authors: Martin DE,Reece M,Reese AC

    更新日期:1984-01-01 00:00:00

  • Evaluation of Cytotoxic Potentials of Novel Cyclooxygenase-2 Inhibitor against ALL Lymphocytes and Normal Lymphocytes and Its Anticancer Effect through Mitochondrial Pathway.

    abstract::In the present study, we searched selective cytotoxicity and mitochondria mediated apoptosis of novel COX-2 inhibitor 2-(4-(Methylsulfonyl)phenyl)imidazo[1,2-a] pyridine-8-carboxylic acid on B-lymphocytes and their mitochondria isolated from normal subjects and acute lymphoblastic leukemia (ALL) patients' blood. Our r...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1808898

    authors: Salimi A,Aghvami M,Azami Movahed M,Zarei MH,Eshghi P,Zarghi A,Pourahmad J

    更新日期:2020-09-01 00:00:00

  • 5-Fluorouracil with folinic acid is not effective against metastatic adenocarcinoma of the lung.

    abstract::Thirty patients with a diagnosis of metastatic adenocarcinoma of the lung were entered on a trial to evaluate the antitumor efficacy of 5-fluorouracil 370 mg/m2 daily for 5 days every four weeks in combination with folinic acid 200 mg/m2, 60 min prior to 5FU. All patients had a good performance status, bidimensionally...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909009012052

    authors: Evans WK,Wierzbicki R,Shepherd FA,Rusthoven J,Stewart DJ,Aitken SE,Maroun JA,Ezzat A

    更新日期:1990-01-01 00:00:00

  • Investigation of Human Cytomegalovirus and Human Papillomavirus in Glioma.

    abstract::The study investigated the human cytomegalovirus (HCMV) and human papillomavirus (HPV) in gliomas. A retrospective study was conducted on 112 samples. HCMV was investigated by PCR, in situ hybridization (ISH) and immunohistochemistry. HPV was tested by PCR and DNA ISH. HCMV was identified in 60 gliomas, including 55 G...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1793352

    authors: Limam S,Missaoui N,Hmissa S,Yacoubi MT,Krifa H,Mokni M,Selmi B

    更新日期:2020-08-01 00:00:00

  • Association between methylation of SHP-1 isoform I and SSTR2A promoter regions with breast and prostate carcinoma development.

    abstract::Methylation pattern is presented here for first time as a potential molecular marker of changes on SSTR2A and SHP-1(I) gene promoter related to breast and prostate carcinoma. Our results have shown low concordances with SSTR2A and methylated state in prostate cancer and moderate relationship with unmethylated CpG-27 i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2014.1001892

    authors: Tiscornia MM,González HS,Lorenzati MA,Zapata PD

    更新日期:2015-03-01 00:00:00

  • Decreased expression and aberrant methylation of Raf kinase inhibitory protein gene in esophageal squamous cell carcinoma.

    abstract::Raf kinase inhibitory protein (RKIP) gene is considered to be a suppressor of metastasis involved in various carcinomas. In the present study, we observed that promoter methylation repressed the expression of RKIP in TE-13 cell line. 5-Aza treatment and stable transfection of RKIP resulted in a significant inhibition ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2012.732164

    authors: Guo W,Dong Z,Lin X,Zhang M,Kuang G,Zhu T

    更新日期:2012-12-01 00:00:00

  • Anticarcinogenic effects of shikaron, a preparation of eight Chinese herbs in mice treated with a carcinogen, N-butyl-N'-butanolnitrosoamine.

    abstract::We studied the effects of Shikaron, which is composed of 8 Chinese herb extracts, on carcinogenesis and the cytotoxic activity and cytokine production of lymphocytes in mice treated with a carcinogen, N-butyl-N'-butanolnitrosoamine (BBN). We found a significantly lower incidence of urinary bladder carcinoma in mice tr...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909809050031

    authors: Kurashige S,Jin R,Akuzawa Y,Endo F

    更新日期:1998-01-01 00:00:00

  • Altered Expression of Sphingosine-1-Phosphate Metabolizing Enzymes in Oral Cancer Correlate With Clinicopathological Attributes.

    abstract::We have determined the gene expression of sphingosine-1-phosphate (S1P) metabolizing enzymes (SphK1, SphK2, SGPL1, SGPP1, SGPP2, PPAP2A, PPAP2B, and PPAP2C) by quantitative real-time polymerase chain reaction in tumor tissues and adjacent normal tissues of 50 oral squamous cell carcinoma (OSCC) patients. Expression of...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2016.1272695

    authors: Vishwakarma S,Agarwal R,Goel SK,Panday RK,Singh R,Sukumaran R,Khare S,Kumar A

    更新日期:2017-02-07 00:00:00

  • Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.

    abstract::We have analyzed allelic loss of the short arm of chromosome 9 in 39 head and neck cancers using 13 polymorphic markers and found two deletions of hot spots at 9p21 and 9p24. Loss of heterozygosity was detected at least at one locus in 28 of 39 cases (71.8%). P16, a well-known tumor suppressor gene, is considered to b...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802563010

    authors: Gunduz E,Gunduz M,Ali MA,Beder L,Tamamura R,Katase N,Tominaga S,Yamanaka N,Shimizu K,Nagatsuka H

    更新日期:2009-07-01 00:00:00

  • Naturally occurring retroviruses (RNA tumor viruses). I.

    abstract::This is the first of two papers describing the naturally occurring retroviruses (RNA tumor viruses). Here, the general properties of these viruses and the biology of the fish, reptilian, chicken, and mouse retroviruses are described. In the next issue of Cancer Investigation the biologic properties of the cat, cattle,...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357908309040934

    authors: Hardy WD Jr

    更新日期:1983-01-01 00:00:00

  • Possible Role and Therapeutic Target of PDGF-D Signalling in Colorectal Cancer.

    abstract::Platelet-derived growth factor D (PDGF-D) has been shown to mediate cellular processes of importance in cancer progression. This study aimed to investigate the expression and putative involvement of PDGF-D signaling in colorectal carcinogenesis. PDGF-D was expressed in vascular endothelial cells in tumor and normal ti...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1576191

    authors: Olsen RS,Dimberg J,Geffers R,Wågsäter D

    更新日期:2019-01-01 00:00:00

  • The biology of interleukin-5 and its receptor.

    abstract::IL-5 is primarily a T-cell-derived cytokine that has multiple regulatory functions on eosinophils and (in the mouse) on antibody-secreting B cells. A complex network of cytokines appear to control transcription of the gene for IL-5 and its production. Abnormally high levels of this cytokine are associated with infecti...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909309011681

    authors: Mahanty S,Nutman TB

    更新日期:1993-01-01 00:00:00

  • Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials.

    abstract::There appears to be exceptional and growing public enthusiasm for botanical, or "herbal", medicines, especially amongst cancer patients. This has recently begun to be matched by increasing scientific attention. Whilst it is known that plant extracts are active against cancer, the standard approach has been to isolate,...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120005926

    authors: Vickers A

    更新日期:2002-01-01 00:00:00

  • Expression of decorin in esophageal cancer in relation to the expression of three isoforms of transforming growth factor-beta (TGF-beta1, -beta2, and -beta3) and matrix metalloproteinase-2 activity.

    abstract::To determine the role of the reactive stroma in cancer progression, we investigated decorin (DCN) and transforming growth factor-beta (TGF-beta expression, and matrix metalloproteinase-2 (MMP-2) activity in the tumorous esophagus. We found statistically insignificantly decreased levels of DCN expression in the patholo...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802527221

    authors: Augoff K,Grabowski K,Rabczynski J,Kolondra A,Tabola R,Sikorski AF

    更新日期:2009-05-01 00:00:00

  • In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.

    abstract::In vivo and in vitro observations of cellular immune response in 70 patients with squamous cell cancer of the oral cavity and in 40 age-matched normal controls, were made using delayed hypersensitivity responses to DNCB, PPD, and Candida albicans extract (Dermatophytin 'O'), absolute lymphocyte counts, absolute T-cell...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908609018450

    authors: Das SN,Khanna NN,Khanna S

    更新日期:1986-01-01 00:00:00

  • Circulating soluble CTLA4 (sCTLA4) is elevated in patients with breast cancer.

    abstract::Soluble CTLA4 (sCTLA4) was assessed in sera of 43 new cases with breast cancer and 44 age- and sex-matched healthy individuals by enzyme-linked immunosorbent assay method. Associations of sCTLA4 levels with the six important CTLA4 Single Nucleotide Polymorphisms (SNPs) and with the resulted haplotypes were investigate...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357901003630934

    authors: Erfani N,Razmkhah M,Ghaderi A

    更新日期:2010-10-01 00:00:00

  • Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.

    abstract:PURPOSE:Human chondrosarcomas are generally resistant to conventional treatments like chemotherapy and radiotherapy. We investigated the effects of BIBR1532, an inhibitor of telomerase on chondrosarcoma cells in vitro. METHODS:Telomerase activity, telomere lengths, growth kinetics and chemosensitivity were analyzed in...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802072905

    authors: Parsch D,Brassat U,Brümmendorf TH,Fellenberg J

    更新日期:2008-07-01 00:00:00

  • Radiation recall dermatitis induced by edatrexate in a patient with breast cancer.

    abstract::Enhancement of radiation injury to the skin and mucous membranes has been observed with a number of chemotherapeutic agents. A 32-year-old woman with metastatic breast cancer received local radiation therapy to the lumbosacral area. Six weeks later, systemic edatrexate therapy was initiated and a localized painful ery...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909509024929

    authors: Perez EA,Campbell DL,Ryu JK

    更新日期:1995-01-01 00:00:00

  • Anemia in cancer.

    abstract::In summary, anemia developing in a patient with cancer can be due to several different factors. A relative failure of erythropoiesis, in conjunction with a modestly shortened erythrocyte survival, is the most likely explanation for the anemia and can occur in patients with or without bone marrow invasion. Several theo...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357908509039786

    authors: Zucker S

    更新日期:1985-01-01 00:00:00

  • Conventional versus high-dose epidoxorubicin as single agent in advanced breast cancer.

    abstract::Between March 1986 and December 1987, two groups of consecutive patients with advanced breast cancer underwent epidoxorubicin (Epidx) monochemotherapy. Twenty-three patients (group A) received Epidx at a dose of 60 mg/m2 and 27 (group B) at a dose of 120 mg/m2 (i.v. every 3 weeks). No patient had undergone anthracycli...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909309024827

    authors: Neri B,Pacini P,Algeri R,Lottini G,Rinaldini M,Tucci E,Pusterla R

    更新日期:1993-01-01 00:00:00

  • Quinacrine Depletes BCR-ABL and Suppresses Ph-Positive Leukemia Cells.

    abstract::Drug resistance to TKIs and the existance of CML leukemia stem cells is an urgent problem. In this study, we demonstrate that quinacrine (QC) induces apoptosis in BCR-ABL positive CML and acute lymphoblastic leukemia (ALL) cells. Interestingly, QC inhibits the colony formation of primary CD34+ progenitor/stem leukemia...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1630633

    authors: Lei H,Tu Y,Yang L,Jin J,Luo H,Xu H,Kang J,Zhou L,Wu Y

    更新日期:2019-01-01 00:00:00

  • ErbB receptors as prognostic and therapeutic drug targets in bone and soft tissue sarcomas.

    abstract::ErbB receptors have been intensely studied to understand their importance in cancer biology and as therapeutic targets, and many ErbB inhibitors are now used in the clinical setting. A large number of studies have been conducted to examine the expression of ErbB family members in bone and soft tissue sarcomas, includi...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2014.964409

    authors: Wang H,Yang Q,Fu Z,Zuo D,Hua Y,Cai Z

    更新日期:2014-12-01 00:00:00

  • Reversible deficiency of serum high density lipoproteins in Hodgkin's disease.

    abstract::An elderly woman with Hodgkin's disease and hepatic involvement but without cholestasis presented with markedly depressed levels of serum esterified cholesterol and high density lipoproteins (HDL). Within five days of her first cycle of chemotherapy her serum HDL-cholesterol rose from 8-10 mg/dl to 88 mg/dl, and level...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908609017510

    authors: Herbert PN,Friedland ML

    更新日期:1986-01-01 00:00:00

  • Activated PKCalpha/ERK1/2 signaling inhibits tamoxifen-induced apoptosis in C6 cells.

    abstract::Data have shown that tamoxifen (TAM) can be used to treat not only breast cancer with positive estrogen receptor (ER), but also negative ER including human glioma. However, the molecular mechanism of this drug against different kinds of cancers remains to be elucidated. In this study, we provided the evidence that PKC...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802672720

    authors: Tian F,Wu H,Li Z,Wang N,Huang J,Li C,Xie F

    更新日期:2009-08-01 00:00:00

  • Chemo/radiotherapy-Induced Bone Marrow Niche Alterations.

    abstract::Bone marrow (BM) niche is a specific microenvironment for hematopoietic stem cells (HSCs) as well as non-hematopoietic cells. Evidence shows that chemo/radiotherapy can lead to the disruption of different properties of HSCs such as proliferation, differentiation, localization, self-renewa, and steady-state of cell pop...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1855353

    authors: Rafieemehr H,Maleki Behzad M,Azandeh S,Farshchi N,Ghasemi Dehcheshmeh M,Saki N

    更新日期:2020-12-10 00:00:00

  • Local delivery of IL-1 alpha polymeric microspheres for the immunotherapy of an experimental fibrosarcoma.

    abstract::The immunotherapeutic effects of interleukin-1 alpha (IL-1 alpha) encapsulated within 1-5 microns-diameter poly (D, L-lactide) microspheres and delivered intratumorally into fibrosarcoma-bearing mice were investigated. Such microspheres are avidly taken up by macrophages, and directing IL-1 alpha into these cells may ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-120023770

    authors: Mullerad J,Cohen S,Benharroch D,Apte RN

    更新日期:2003-01-01 00:00:00

  • Cells of chemically induced tumors differentially express major histocompatibility complex class I antigens.

    abstract::Several recent studies have indicated that alterations in expression of major histocompatibility complex (MHC) antigens by tumor cells affects the ability of the host to mount an effective antitumor immune response. To investigate whether newly induced tumors frequently exhibit altered MHC antigen expression, we used ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909109021324

    authors: Reagan WJ,Pardi D,Callahan GN

    更新日期:1991-01-01 00:00:00